data_2VV9 # _entry.id 2VV9 # _audit_conform.dict_name mmcif_pdbx.dic _audit_conform.dict_version 5.307 _audit_conform.dict_location http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic # loop_ _database_2.database_id _database_2.database_code PDB 2VV9 PDBE EBI-36484 WWPDB D_1290036484 # loop_ _pdbx_database_related.db_name _pdbx_database_related.db_id _pdbx_database_related.content_type _pdbx_database_related.details PDB 1PYE unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR' PDB 1H08 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2VTH unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2B53 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325' PDB 1V1K unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1OKV unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2' PDB 1H25 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1KE7 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2- ONE ; PDB 1PXK unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE ; PDB 2BHH unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE' PDB 2VTA unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2UUE unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1GZ8 unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE ; PDB 1E1V unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058' PDB 1OL2 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1H27 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27' PDB 1JSV unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4-[(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE' PDB 2B52 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562' PDB 1KE5 unspecified 'CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE' PDB 1FIN unspecified 'CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX' PDB 2C5O unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C68 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2VTT unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1P2A unspecified 'THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR' PDB 2VTQ unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2C4G unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514' PDB 1W0X unspecified 'CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.' PDB 1H1Q unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094' PDB 1PXO unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2-AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)-AMINE ; PDB 1KE9 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- DIHYDRO-1H-INDOLE ; PDB 2A0C unspecified 'HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR' PDB 1HCK unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1JSU unspecified 'P27(KIP1)/CYCLIN A/CDK2 COMPLEX' PDB 1PXN unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4-METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL ; PDB 2UZE unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2VTM unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2V0D unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1OIQ unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1H1R unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086' PDB 2IW8 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR' PDB 1PW2 unspecified 'APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1GIH unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1HCL unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 2VTN unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1JST unspecified 'PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A' PDB 1OIU unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 1B38 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2' PDB 1PXM unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL' PDB 1FQ1 unspecified 'CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX WITH PHOSPHO-CDK2' PDB 1VYW unspecified 'STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137' PDB 1H1P unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058' PDB 2C69 unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1URC unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2' PDB 1PXI unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5-DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE' PDB 2C6I unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1YKR unspecified 'CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR' PDB 2UZD unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2C5Y unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C6K unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1WCC unspecified 'SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY' PDB 2J9M unspecified 'CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE' PDB 1VYZ unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227' PDB 2VTI unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1JVP unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH PKF049-365' PDB 1W98 unspecified 'THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E' PDB 1PKD unspecified 'THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A' PDB 1P5E unspecified 'THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS)' PDB 2VTS unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2C5P unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2UZN unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2B54 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305' PDB 1PXJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE' PDB 1KE6 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE ; PDB 2UZL unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 2CCI unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6' PDB 2G9X unspecified 'STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/ CYCLIN A INCOMPLEX WITH THE INHIBITOR NU6271' PDB 2BKZ unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611' PDB 1Y91 unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' PDB 2IW6 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1GIJ unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1R78 unspecified 'CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR' PDB 1H0V unspecified ;HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE ; PDB 2IW9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR' PDB 1W8C unspecified 'CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2' PDB 1BUH unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE-REGULATORY PROTEIN CKSHS1' PDB 2BPM unspecified 'STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529' PDB 2BTS unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032' PDB 1FVV unspecified 'THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR' PDB 1OKW unspecified 'CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2' PDB 2VTP unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2A4L unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE' PDB 2C6T unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1FVT unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN OXINDOLE INHIBITOR' PDB 1QMZ unspecified 'PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX' PDB 2VU3 unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1OGU unspecified ;STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR ; PDB 2B55 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE DIN-101312' PDB 1PF8 unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH A NUCLEOSIDE INHIBITOR' PDB 1H1S unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102' PDB 2C5V unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2JGZ unspecified 'CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B' PDB 2BHE unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO- INDIRUBINE' PDB 1URW unspecified 'CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE' PDB 1OIY unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2C6L unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1F5Q unspecified 'CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDANT KINASE 2' PDB 2C6O unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 2VTL unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1OL1 unspecified 'CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2' PDB 1H01 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2UZB unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1OIR unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 1OI9 unspecified 'STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR' PDB 2VTJ unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 2CJM unspecified 'MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE' PDB 2C5N unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C5X unspecified 'DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN' PDB 2C6M unspecified 'CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR' PDB 1OIT unspecified ;IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION ; PDB 2V22 unspecified 'REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS' PDB 1GY3 unspecified 'PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE' PDB 1GII unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR' PDB 1DI8 unspecified 'THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE' PDB 1E9H unspecified 'THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5- SULPHONATE BOUND' PDB 2VTO unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1DM2 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE' PDB 2UZO unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR' PDB 1H24 unspecified 'CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F' PDB 1H00 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 2EXM unspecified 'HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE' PDB 2CLX unspecified ;4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS ; PDB 1PXP unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1,4-DIAMINE ; PDB 2CCH unspecified ;THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE ; PDB 1B39 unspecified 'HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160' PDB 2BTR unspecified 'STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873' PDB 1AQ1 unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE' PDB 1H0W unspecified 'HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE' PDB 1CKP unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B' PDB 1G5S unspecified 'CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN COMPLEX WITH THE INHIBITOR H717' PDB 1H28 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107' PDB 1KE8 unspecified ;CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL)BENZENESULFONAMIDE ; PDB 1PXL unspecified ;HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)-AMINE ; PDB 2VTR unspecified ;IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6 -DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3- CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X- RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. ; PDB 1H26 unspecified 'CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53' PDB 1H07 unspecified 'CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR' PDB 1E1X unspecified 'HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027' PDB 1Y8Y unspecified 'CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR' # _pdbx_database_status.status_code REL _pdbx_database_status.entry_id 2VV9 _pdbx_database_status.deposit_site PDBE _pdbx_database_status.process_site PDBE _pdbx_database_status.SG_entry . _pdbx_database_status.recvd_initial_deposition_date 2008-06-04 _pdbx_database_status.pdb_format_compatible Y _pdbx_database_status.status_code_sf ? _pdbx_database_status.status_code_mr ? _pdbx_database_status.status_code_cs ? _pdbx_database_status.methods_development_category ? # loop_ _audit_author.name _audit_author.pdbx_ordinal 'Acton, D.G.' 1 'Anderson, M.' 2 'Andrews, D.M.' 3 'Barker, A.J.' 4 'Brassington, C.A.' 5 'Finlay, M.R.' 6 'Fisher, E.' 7 'Gerhardt, S.' 8 'Graham, M.A.' 9 'Green, C.P.' 10 'Heaton, D.W.' 11 'Loddick, S.A.' 12 'Morgentin, R.' 13 'Read, J.' 14 'Roberts, A.' 15 'Stanway, J.' 16 'Tucker, J.A.' 17 'Weir, H.M.' 18 # _citation.id primary _citation.title 'Imidazole Piperazines: Sar and Development of a Potent Class of Cyclin-Dependent Kinase Inhibitors with a Novel Binding Mode.' _citation.journal_abbrev Bioorg.Med.Chem.Lett. _citation.journal_volume 18 _citation.page_first 4442 _citation.page_last ? _citation.year 2008 _citation.journal_id_ASTM BMCLE8 _citation.country UK _citation.journal_id_ISSN 0960-894X _citation.journal_id_CSD 1127 _citation.book_publisher ? _citation.pdbx_database_id_PubMed 18617397 _citation.pdbx_database_id_DOI 10.1016/J.BMCL.2008.06.027 # loop_ _citation_author.citation_id _citation_author.name _citation_author.ordinal _citation_author.identifier_ORCID primary 'Finlay, M.R.' 1 ? primary 'Acton, D.G.' 2 ? primary 'Andrews, D.M.' 3 ? primary 'Barker, A.J.' 4 ? primary 'Dennis, M.' 5 ? primary 'Fisher, E.' 6 ? primary 'Graham, M.A.' 7 ? primary 'Green, C.P.' 8 ? primary 'Heaton, D.W.' 9 ? primary 'Karoutchi, G.' 10 ? primary 'Loddick, S.A.' 11 ? primary 'Morgentin, R.' 12 ? primary 'Roberts, A.' 13 ? primary 'Tucker, J.A.' 14 ? primary 'Weir, H.M.' 15 ? # _cell.entry_id 2VV9 _cell.length_a 53.252 _cell.length_b 71.153 _cell.length_c 71.933 _cell.angle_alpha 90.00 _cell.angle_beta 90.00 _cell.angle_gamma 90.00 _cell.Z_PDB 4 _cell.pdbx_unique_axis ? # _symmetry.entry_id 2VV9 _symmetry.space_group_name_H-M 'P 21 21 21' _symmetry.pdbx_full_space_group_name_H-M ? _symmetry.cell_setting ? _symmetry.Int_Tables_number 19 # loop_ _entity.id _entity.type _entity.src_method _entity.pdbx_description _entity.formula_weight _entity.pdbx_number_of_molecules _entity.pdbx_ec _entity.pdbx_mutation _entity.pdbx_fragment _entity.details 1 polymer man 'CELL DIVISION PROTEIN KINASE 2' 34002.527 1 2.7.11.22 ? ? 'ACETYLATION AT N-TERMINAL METHIONINE' 2 non-polymer syn '2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol' 435.522 1 ? ? ? ? 3 water nat water 18.015 152 ? ? ? ? # _entity_name_com.entity_id 1 _entity_name_com.name 'P33 PROTEIN KINASE, CYCLIN DEPENDENT KINASE 2' # _entity_poly.entity_id 1 _entity_poly.type 'polypeptide(L)' _entity_poly.nstd_linkage no _entity_poly.nstd_monomer yes _entity_poly.pdbx_seq_one_letter_code ;(ACE)MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_seq_one_letter_code_can ;XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL ; _entity_poly.pdbx_strand_id A _entity_poly.pdbx_target_identifier ? # loop_ _entity_poly_seq.entity_id _entity_poly_seq.num _entity_poly_seq.mon_id _entity_poly_seq.hetero 1 1 ACE n 1 2 MET n 1 3 GLU n 1 4 ASN n 1 5 PHE n 1 6 GLN n 1 7 LYS n 1 8 VAL n 1 9 GLU n 1 10 LYS n 1 11 ILE n 1 12 GLY n 1 13 GLU n 1 14 GLY n 1 15 THR n 1 16 TYR n 1 17 GLY n 1 18 VAL n 1 19 VAL n 1 20 TYR n 1 21 LYS n 1 22 ALA n 1 23 ARG n 1 24 ASN n 1 25 LYS n 1 26 LEU n 1 27 THR n 1 28 GLY n 1 29 GLU n 1 30 VAL n 1 31 VAL n 1 32 ALA n 1 33 LEU n 1 34 LYS n 1 35 LYS n 1 36 ILE n 1 37 ARG n 1 38 LEU n 1 39 ASP n 1 40 THR n 1 41 GLU n 1 42 THR n 1 43 GLU n 1 44 GLY n 1 45 VAL n 1 46 PRO n 1 47 SER n 1 48 THR n 1 49 ALA n 1 50 ILE n 1 51 ARG n 1 52 GLU n 1 53 ILE n 1 54 SER n 1 55 LEU n 1 56 LEU n 1 57 LYS n 1 58 GLU n 1 59 LEU n 1 60 ASN n 1 61 HIS n 1 62 PRO n 1 63 ASN n 1 64 ILE n 1 65 VAL n 1 66 LYS n 1 67 LEU n 1 68 LEU n 1 69 ASP n 1 70 VAL n 1 71 ILE n 1 72 HIS n 1 73 THR n 1 74 GLU n 1 75 ASN n 1 76 LYS n 1 77 LEU n 1 78 TYR n 1 79 LEU n 1 80 VAL n 1 81 PHE n 1 82 GLU n 1 83 PHE n 1 84 LEU n 1 85 HIS n 1 86 GLN n 1 87 ASP n 1 88 LEU n 1 89 LYS n 1 90 LYS n 1 91 PHE n 1 92 MET n 1 93 ASP n 1 94 ALA n 1 95 SER n 1 96 ALA n 1 97 LEU n 1 98 THR n 1 99 GLY n 1 100 ILE n 1 101 PRO n 1 102 LEU n 1 103 PRO n 1 104 LEU n 1 105 ILE n 1 106 LYS n 1 107 SER n 1 108 TYR n 1 109 LEU n 1 110 PHE n 1 111 GLN n 1 112 LEU n 1 113 LEU n 1 114 GLN n 1 115 GLY n 1 116 LEU n 1 117 ALA n 1 118 PHE n 1 119 CYS n 1 120 HIS n 1 121 SER n 1 122 HIS n 1 123 ARG n 1 124 VAL n 1 125 LEU n 1 126 HIS n 1 127 ARG n 1 128 ASP n 1 129 LEU n 1 130 LYS n 1 131 PRO n 1 132 GLN n 1 133 ASN n 1 134 LEU n 1 135 LEU n 1 136 ILE n 1 137 ASN n 1 138 THR n 1 139 GLU n 1 140 GLY n 1 141 ALA n 1 142 ILE n 1 143 LYS n 1 144 LEU n 1 145 ALA n 1 146 ASP n 1 147 PHE n 1 148 GLY n 1 149 LEU n 1 150 ALA n 1 151 ARG n 1 152 ALA n 1 153 PHE n 1 154 GLY n 1 155 VAL n 1 156 PRO n 1 157 VAL n 1 158 ARG n 1 159 THR n 1 160 TYR n 1 161 THR n 1 162 HIS n 1 163 GLU n 1 164 VAL n 1 165 VAL n 1 166 THR n 1 167 LEU n 1 168 TRP n 1 169 TYR n 1 170 ARG n 1 171 ALA n 1 172 PRO n 1 173 GLU n 1 174 ILE n 1 175 LEU n 1 176 LEU n 1 177 GLY n 1 178 CYS n 1 179 LYS n 1 180 TYR n 1 181 TYR n 1 182 SER n 1 183 THR n 1 184 ALA n 1 185 VAL n 1 186 ASP n 1 187 ILE n 1 188 TRP n 1 189 SER n 1 190 LEU n 1 191 GLY n 1 192 CYS n 1 193 ILE n 1 194 PHE n 1 195 ALA n 1 196 GLU n 1 197 MET n 1 198 VAL n 1 199 THR n 1 200 ARG n 1 201 ARG n 1 202 ALA n 1 203 LEU n 1 204 PHE n 1 205 PRO n 1 206 GLY n 1 207 ASP n 1 208 SER n 1 209 GLU n 1 210 ILE n 1 211 ASP n 1 212 GLN n 1 213 LEU n 1 214 PHE n 1 215 ARG n 1 216 ILE n 1 217 PHE n 1 218 ARG n 1 219 THR n 1 220 LEU n 1 221 GLY n 1 222 THR n 1 223 PRO n 1 224 ASP n 1 225 GLU n 1 226 VAL n 1 227 VAL n 1 228 TRP n 1 229 PRO n 1 230 GLY n 1 231 VAL n 1 232 THR n 1 233 SER n 1 234 MET n 1 235 PRO n 1 236 ASP n 1 237 TYR n 1 238 LYS n 1 239 PRO n 1 240 SER n 1 241 PHE n 1 242 PRO n 1 243 LYS n 1 244 TRP n 1 245 ALA n 1 246 ARG n 1 247 GLN n 1 248 ASP n 1 249 PHE n 1 250 SER n 1 251 LYS n 1 252 VAL n 1 253 VAL n 1 254 PRO n 1 255 PRO n 1 256 LEU n 1 257 ASP n 1 258 GLU n 1 259 ASP n 1 260 GLY n 1 261 ARG n 1 262 SER n 1 263 LEU n 1 264 LEU n 1 265 SER n 1 266 GLN n 1 267 MET n 1 268 LEU n 1 269 HIS n 1 270 TYR n 1 271 ASP n 1 272 PRO n 1 273 ASN n 1 274 LYS n 1 275 ARG n 1 276 ILE n 1 277 SER n 1 278 ALA n 1 279 LYS n 1 280 ALA n 1 281 ALA n 1 282 LEU n 1 283 ALA n 1 284 HIS n 1 285 PRO n 1 286 PHE n 1 287 PHE n 1 288 GLN n 1 289 ASP n 1 290 VAL n 1 291 THR n 1 292 LYS n 1 293 PRO n 1 294 VAL n 1 295 PRO n 1 296 HIS n 1 297 LEU n 1 298 ARG n 1 299 LEU n # _entity_src_gen.entity_id 1 _entity_src_gen.pdbx_src_id 1 _entity_src_gen.pdbx_alt_source_flag sample _entity_src_gen.pdbx_seq_type ? _entity_src_gen.pdbx_beg_seq_num ? _entity_src_gen.pdbx_end_seq_num ? _entity_src_gen.gene_src_common_name HUMAN _entity_src_gen.gene_src_genus ? _entity_src_gen.pdbx_gene_src_gene ? _entity_src_gen.gene_src_species ? _entity_src_gen.gene_src_strain ? _entity_src_gen.gene_src_tissue ? _entity_src_gen.gene_src_tissue_fraction ? _entity_src_gen.gene_src_details ? _entity_src_gen.pdbx_gene_src_fragment ? _entity_src_gen.pdbx_gene_src_scientific_name 'HOMO SAPIENS' _entity_src_gen.pdbx_gene_src_ncbi_taxonomy_id 9606 _entity_src_gen.pdbx_gene_src_variant ? _entity_src_gen.pdbx_gene_src_cell_line ? _entity_src_gen.pdbx_gene_src_atcc ? _entity_src_gen.pdbx_gene_src_organ ? _entity_src_gen.pdbx_gene_src_organelle ? _entity_src_gen.pdbx_gene_src_cell ? _entity_src_gen.pdbx_gene_src_cellular_location ? _entity_src_gen.host_org_common_name ? _entity_src_gen.pdbx_host_org_scientific_name 'SPODOPTERA FRUGIPERDA' _entity_src_gen.pdbx_host_org_ncbi_taxonomy_id 7108 _entity_src_gen.host_org_genus ? _entity_src_gen.pdbx_host_org_gene ? _entity_src_gen.pdbx_host_org_organ ? _entity_src_gen.host_org_species ? _entity_src_gen.pdbx_host_org_tissue ? _entity_src_gen.pdbx_host_org_tissue_fraction ? _entity_src_gen.pdbx_host_org_strain ? _entity_src_gen.pdbx_host_org_variant ? _entity_src_gen.pdbx_host_org_cell_line Sf21 _entity_src_gen.pdbx_host_org_atcc ? _entity_src_gen.pdbx_host_org_culture_collection ? _entity_src_gen.pdbx_host_org_cell ? _entity_src_gen.pdbx_host_org_organelle ? _entity_src_gen.pdbx_host_org_cellular_location ? _entity_src_gen.pdbx_host_org_vector_type BACULOVIRUS _entity_src_gen.pdbx_host_org_vector ? _entity_src_gen.host_org_details ? _entity_src_gen.expression_system_id ? _entity_src_gen.plasmid_name ? _entity_src_gen.plasmid_details ? _entity_src_gen.pdbx_description ? # _struct_ref.id 1 _struct_ref.db_name UNP _struct_ref.db_code CDK2_HUMAN _struct_ref.entity_id 1 _struct_ref.pdbx_seq_one_letter_code ? _struct_ref.pdbx_align_begin ? _struct_ref.pdbx_db_accession P24941 _struct_ref.pdbx_db_isoform ? # _struct_ref_seq.align_id 1 _struct_ref_seq.ref_id 1 _struct_ref_seq.pdbx_PDB_id_code 2VV9 _struct_ref_seq.pdbx_strand_id A _struct_ref_seq.seq_align_beg 2 _struct_ref_seq.pdbx_seq_align_beg_ins_code ? _struct_ref_seq.seq_align_end 299 _struct_ref_seq.pdbx_seq_align_end_ins_code ? _struct_ref_seq.pdbx_db_accession P24941 _struct_ref_seq.db_align_beg 1 _struct_ref_seq.pdbx_db_align_beg_ins_code ? _struct_ref_seq.db_align_end 298 _struct_ref_seq.pdbx_db_align_end_ins_code ? _struct_ref_seq.pdbx_auth_seq_align_beg 1 _struct_ref_seq.pdbx_auth_seq_align_end 298 # loop_ _chem_comp.id _chem_comp.type _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.formula _chem_comp.formula_weight ACE non-polymer . 'ACETYL GROUP' ? 'C2 H4 O' 44.053 ALA 'L-peptide linking' y ALANINE ? 'C3 H7 N O2' 89.093 ARG 'L-peptide linking' y ARGININE ? 'C6 H15 N4 O2 1' 175.209 ASN 'L-peptide linking' y ASPARAGINE ? 'C4 H8 N2 O3' 132.118 ASP 'L-peptide linking' y 'ASPARTIC ACID' ? 'C4 H7 N O4' 133.103 CYS 'L-peptide linking' y CYSTEINE ? 'C3 H7 N O2 S' 121.158 GLN 'L-peptide linking' y GLUTAMINE ? 'C5 H10 N2 O3' 146.144 GLU 'L-peptide linking' y 'GLUTAMIC ACID' ? 'C5 H9 N O4' 147.129 GLY 'peptide linking' y GLYCINE ? 'C2 H5 N O2' 75.067 HIS 'L-peptide linking' y HISTIDINE ? 'C6 H10 N3 O2 1' 156.162 HOH non-polymer . WATER ? 'H2 O' 18.015 ILE 'L-peptide linking' y ISOLEUCINE ? 'C6 H13 N O2' 131.173 IM9 non-polymer . '2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol' ? 'C23 H29 N7 O2' 435.522 LEU 'L-peptide linking' y LEUCINE ? 'C6 H13 N O2' 131.173 LYS 'L-peptide linking' y LYSINE ? 'C6 H15 N2 O2 1' 147.195 MET 'L-peptide linking' y METHIONINE ? 'C5 H11 N O2 S' 149.211 PHE 'L-peptide linking' y PHENYLALANINE ? 'C9 H11 N O2' 165.189 PRO 'L-peptide linking' y PROLINE ? 'C5 H9 N O2' 115.130 SER 'L-peptide linking' y SERINE ? 'C3 H7 N O3' 105.093 THR 'L-peptide linking' y THREONINE ? 'C4 H9 N O3' 119.119 TRP 'L-peptide linking' y TRYPTOPHAN ? 'C11 H12 N2 O2' 204.225 TYR 'L-peptide linking' y TYROSINE ? 'C9 H11 N O3' 181.189 VAL 'L-peptide linking' y VALINE ? 'C5 H11 N O2' 117.146 # _exptl.entry_id 2VV9 _exptl.method 'X-RAY DIFFRACTION' _exptl.crystals_number 1 # _exptl_crystal.id 1 _exptl_crystal.density_meas ? _exptl_crystal.density_Matthews 2 _exptl_crystal.density_percent_sol 39 _exptl_crystal.description NONE # _exptl_crystal_grow.crystal_id 1 _exptl_crystal_grow.method ? _exptl_crystal_grow.temp ? _exptl_crystal_grow.temp_details ? _exptl_crystal_grow.pH 7.5 _exptl_crystal_grow.pdbx_pH_range ? _exptl_crystal_grow.pdbx_details '8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE' # _diffrn.id 1 _diffrn.ambient_temp 100 _diffrn.ambient_temp_details ? _diffrn.crystal_id 1 # _diffrn_detector.diffrn_id 1 _diffrn_detector.detector CCD _diffrn_detector.type 'ADSC QUANTUM-4' _diffrn_detector.pdbx_collection_date 2004-03-11 _diffrn_detector.details ? # _diffrn_radiation.diffrn_id 1 _diffrn_radiation.wavelength_id 1 _diffrn_radiation.pdbx_monochromatic_or_laue_m_l M _diffrn_radiation.monochromator ? _diffrn_radiation.pdbx_diffrn_protocol 'SINGLE WAVELENGTH' _diffrn_radiation.pdbx_scattering_type x-ray # _diffrn_radiation_wavelength.id 1 _diffrn_radiation_wavelength.wavelength 0.9795 _diffrn_radiation_wavelength.wt 1.0 # _diffrn_source.diffrn_id 1 _diffrn_source.source SYNCHROTRON _diffrn_source.type 'SRS BEAMLINE PX14.2' _diffrn_source.pdbx_synchrotron_site SRS _diffrn_source.pdbx_synchrotron_beamline PX14.2 _diffrn_source.pdbx_wavelength 0.9795 _diffrn_source.pdbx_wavelength_list ? # _reflns.pdbx_diffrn_id 1 _reflns.pdbx_ordinal 1 _reflns.entry_id 2VV9 _reflns.observed_criterion_sigma_I 3.7 _reflns.observed_criterion_sigma_F ? _reflns.d_resolution_low 27.52 _reflns.d_resolution_high 1.90 _reflns.number_obs 21456 _reflns.number_all ? _reflns.percent_possible_obs 97.3 _reflns.pdbx_Rmerge_I_obs 0.04 _reflns.pdbx_Rsym_value ? _reflns.pdbx_netI_over_sigmaI 16.05 _reflns.B_iso_Wilson_estimate ? _reflns.pdbx_redundancy 2.67 # _reflns_shell.pdbx_diffrn_id 1 _reflns_shell.pdbx_ordinal 1 _reflns_shell.d_res_high 1.90 _reflns_shell.d_res_low 1.92 _reflns_shell.percent_possible_all 88.3 _reflns_shell.Rmerge_I_obs 0.32 _reflns_shell.pdbx_Rsym_value ? _reflns_shell.meanI_over_sigI_obs 1.80 _reflns_shell.pdbx_redundancy 2.16 # _refine.pdbx_refine_id 'X-RAY DIFFRACTION' _refine.entry_id 2VV9 _refine.pdbx_diffrn_id 1 _refine.pdbx_TLS_residual_ADP_flag 'LIKELY RESIDUAL' _refine.ls_number_reflns_obs 19641 _refine.ls_number_reflns_all ? _refine.pdbx_ls_sigma_I ? _refine.pdbx_ls_sigma_F ? _refine.pdbx_data_cutoff_high_absF ? _refine.pdbx_data_cutoff_low_absF ? _refine.pdbx_data_cutoff_high_rms_absF ? _refine.ls_d_res_low 27.52 _refine.ls_d_res_high 1.90 _refine.ls_percent_reflns_obs 93.5 _refine.ls_R_factor_obs 0.191 _refine.ls_R_factor_all ? _refine.ls_R_factor_R_work 0.189 _refine.ls_R_factor_R_free 0.228 _refine.ls_R_factor_R_free_error ? _refine.ls_R_factor_R_free_error_details ? _refine.ls_percent_reflns_R_free 5.100 _refine.ls_number_reflns_R_free 1063 _refine.ls_number_parameters ? _refine.ls_number_restraints ? _refine.occupancy_min ? _refine.occupancy_max ? _refine.correlation_coeff_Fo_to_Fc 0.958 _refine.correlation_coeff_Fo_to_Fc_free 0.946 _refine.B_iso_mean 22.15 _refine.aniso_B[1][1] -0.35000 _refine.aniso_B[2][2] 2.17000 _refine.aniso_B[3][3] -1.82000 _refine.aniso_B[1][2] 0.00000 _refine.aniso_B[1][3] 0.00000 _refine.aniso_B[2][3] 0.00000 _refine.solvent_model_details 'BABINET MODEL WITH MASK' _refine.solvent_model_param_ksol ? _refine.solvent_model_param_bsol ? _refine.pdbx_solvent_vdw_probe_radii 1.40 _refine.pdbx_solvent_ion_probe_radii 0.80 _refine.pdbx_solvent_shrinkage_radii 0.80 _refine.pdbx_ls_cross_valid_method THROUGHOUT _refine.details 'HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. SIDE-CHAINS OF DISORDERED RESIDUES HAVE BEEN TRUNCATED TO CBETA' _refine.pdbx_starting_model 'IN-HOUSE CDK2 STRUCTURE' _refine.pdbx_method_to_determine_struct 'MOLECULAR REPLACEMENT' _refine.pdbx_isotropic_thermal_model ? _refine.pdbx_stereochemistry_target_values 'MAXIMUM LIKELIHOOD' _refine.pdbx_stereochem_target_val_spec_case ? _refine.pdbx_R_Free_selection_details RANDOM _refine.pdbx_overall_ESU_R 0.183 _refine.pdbx_overall_ESU_R_Free 0.157 _refine.overall_SU_ML 0.116 _refine.pdbx_overall_phase_error ? _refine.overall_SU_B 4.115 _refine.overall_SU_R_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_free_Cruickshank_DPI ? _refine.pdbx_overall_SU_R_Blow_DPI ? _refine.pdbx_overall_SU_R_free_Blow_DPI ? # _refine_hist.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_hist.cycle_id LAST _refine_hist.pdbx_number_atoms_protein 2182 _refine_hist.pdbx_number_atoms_nucleic_acid 0 _refine_hist.pdbx_number_atoms_ligand 32 _refine_hist.number_atoms_solvent 152 _refine_hist.number_atoms_total 2366 _refine_hist.d_res_high 1.90 _refine_hist.d_res_low 27.52 # loop_ _refine_ls_restr.type _refine_ls_restr.dev_ideal _refine_ls_restr.dev_ideal_target _refine_ls_restr.weight _refine_ls_restr.number _refine_ls_restr.pdbx_refine_id _refine_ls_restr.pdbx_restraint_function r_bond_refined_d 0.013 0.022 ? 2297 'X-RAY DIFFRACTION' ? r_bond_other_d 0.002 0.020 ? 2132 'X-RAY DIFFRACTION' ? r_angle_refined_deg 1.501 1.981 ? 3117 'X-RAY DIFFRACTION' ? r_angle_other_deg 1.465 3.000 ? 4960 'X-RAY DIFFRACTION' ? r_dihedral_angle_1_deg 6.585 5.000 ? 276 'X-RAY DIFFRACTION' ? r_dihedral_angle_2_deg ? ? ? ? 'X-RAY DIFFRACTION' ? r_dihedral_angle_3_deg ? ? ? ? 'X-RAY DIFFRACTION' ? r_dihedral_angle_4_deg ? ? ? ? 'X-RAY DIFFRACTION' ? r_chiral_restr 0.082 0.200 ? 349 'X-RAY DIFFRACTION' ? r_gen_planes_refined 0.005 0.020 ? 2483 'X-RAY DIFFRACTION' ? r_gen_planes_other 0.003 0.020 ? 455 'X-RAY DIFFRACTION' ? r_nbd_refined 0.230 0.200 ? 478 'X-RAY DIFFRACTION' ? r_nbd_other 0.253 0.200 ? 2319 'X-RAY DIFFRACTION' ? r_nbtor_refined ? ? ? ? 'X-RAY DIFFRACTION' ? r_nbtor_other 0.093 0.200 ? 1234 'X-RAY DIFFRACTION' ? r_xyhbond_nbd_refined 0.159 0.200 ? 113 'X-RAY DIFFRACTION' ? r_xyhbond_nbd_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_metal_ion_refined ? ? ? ? 'X-RAY DIFFRACTION' ? r_metal_ion_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_symmetry_vdw_refined 0.123 0.200 ? 10 'X-RAY DIFFRACTION' ? r_symmetry_vdw_other 0.322 0.200 ? 64 'X-RAY DIFFRACTION' ? r_symmetry_hbond_refined 0.167 0.200 ? 25 'X-RAY DIFFRACTION' ? r_symmetry_hbond_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_symmetry_metal_ion_refined ? ? ? ? 'X-RAY DIFFRACTION' ? r_symmetry_metal_ion_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_mcbond_it 0.694 1.500 ? 1400 'X-RAY DIFFRACTION' ? r_mcbond_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_mcangle_it 1.266 2.000 ? 2260 'X-RAY DIFFRACTION' ? r_mcangle_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_scbond_it 1.894 3.000 ? 897 'X-RAY DIFFRACTION' ? r_scbond_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_scangle_it 3.108 4.500 ? 857 'X-RAY DIFFRACTION' ? r_scangle_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_long_range_B_refined ? ? ? ? 'X-RAY DIFFRACTION' ? r_long_range_B_other ? ? ? ? 'X-RAY DIFFRACTION' ? r_rigid_bond_restr ? ? ? ? 'X-RAY DIFFRACTION' ? r_sphericity_free ? ? ? ? 'X-RAY DIFFRACTION' ? r_sphericity_bonded ? ? ? ? 'X-RAY DIFFRACTION' ? # _refine_ls_shell.pdbx_refine_id 'X-RAY DIFFRACTION' _refine_ls_shell.pdbx_total_number_of_bins_used 20 _refine_ls_shell.d_res_high 1.90 _refine_ls_shell.d_res_low 1.95 _refine_ls_shell.number_reflns_R_work 1073 _refine_ls_shell.R_factor_R_work 0.2680 _refine_ls_shell.percent_reflns_obs ? _refine_ls_shell.R_factor_R_free 0.3260 _refine_ls_shell.R_factor_R_free_error ? _refine_ls_shell.percent_reflns_R_free ? _refine_ls_shell.number_reflns_R_free 63 _refine_ls_shell.number_reflns_all ? _refine_ls_shell.R_factor_all ? # _struct.entry_id 2VV9 _struct.title 'CDK2 in complex with an imidazole piperazine' _struct.pdbx_descriptor 'CELL DIVISION PROTEIN KINASE 2 (E.C.2.7.11.22)' _struct.pdbx_model_details ? _struct.pdbx_CASP_flag ? _struct.pdbx_model_type_details ? # _struct_keywords.entry_id 2VV9 _struct_keywords.pdbx_keywords TRANSFERASE _struct_keywords.text ;KINASE, MITOSIS, CELL CYCLE, TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, CELL DIVISION, PHOSPHOPROTEIN, PHOSPHORYLATION, NUCLEOTIDE-BINDING ; # loop_ _struct_asym.id _struct_asym.pdbx_blank_PDB_chainid_flag _struct_asym.pdbx_modified _struct_asym.entity_id _struct_asym.details A N N 1 ? B N N 2 ? C N N 3 ? # _struct_biol.id 1 # loop_ _struct_conf.conf_type_id _struct_conf.id _struct_conf.pdbx_PDB_helix_id _struct_conf.beg_label_comp_id _struct_conf.beg_label_asym_id _struct_conf.beg_label_seq_id _struct_conf.pdbx_beg_PDB_ins_code _struct_conf.end_label_comp_id _struct_conf.end_label_asym_id _struct_conf.end_label_seq_id _struct_conf.pdbx_end_PDB_ins_code _struct_conf.beg_auth_comp_id _struct_conf.beg_auth_asym_id _struct_conf.beg_auth_seq_id _struct_conf.end_auth_comp_id _struct_conf.end_auth_asym_id _struct_conf.end_auth_seq_id _struct_conf.pdbx_PDB_helix_class _struct_conf.details _struct_conf.pdbx_PDB_helix_length HELX_P HELX_P1 1 PRO A 46 ? LYS A 57 ? PRO A 45 LYS A 56 1 ? 12 HELX_P HELX_P2 2 LEU A 88 ? SER A 95 ? LEU A 87 SER A 94 1 ? 8 HELX_P HELX_P3 3 PRO A 101 ? HIS A 122 ? PRO A 100 HIS A 121 1 ? 22 HELX_P HELX_P4 4 LYS A 130 ? GLN A 132 ? LYS A 129 GLN A 131 5 ? 3 HELX_P HELX_P5 5 ALA A 171 ? LEU A 176 ? ALA A 170 LEU A 175 1 ? 6 HELX_P HELX_P6 6 THR A 183 ? ARG A 200 ? THR A 182 ARG A 199 1 ? 18 HELX_P HELX_P7 7 SER A 208 ? GLY A 221 ? SER A 207 GLY A 220 1 ? 14 HELX_P HELX_P8 8 GLY A 230 ? MET A 234 ? GLY A 229 MET A 233 5 ? 5 HELX_P HELX_P9 9 ASP A 248 ? VAL A 253 ? ASP A 247 VAL A 252 1 ? 6 HELX_P HELX_P10 10 ASP A 257 ? LEU A 268 ? ASP A 256 LEU A 267 1 ? 12 HELX_P HELX_P11 11 SER A 277 ? LEU A 282 ? SER A 276 LEU A 281 1 ? 6 HELX_P HELX_P12 12 ALA A 283 ? GLN A 288 ? ALA A 282 GLN A 287 5 ? 6 # _struct_conf_type.id HELX_P _struct_conf_type.criteria ? _struct_conf_type.reference ? # _struct_conn.id covale1 _struct_conn.conn_type_id covale _struct_conn.pdbx_leaving_atom_flag both _struct_conn.pdbx_PDB_id ? _struct_conn.ptnr1_label_asym_id A _struct_conn.ptnr1_label_comp_id ACE _struct_conn.ptnr1_label_seq_id 1 _struct_conn.ptnr1_label_atom_id C _struct_conn.pdbx_ptnr1_label_alt_id ? _struct_conn.pdbx_ptnr1_PDB_ins_code ? _struct_conn.pdbx_ptnr1_standard_comp_id ? _struct_conn.ptnr1_symmetry 1_555 _struct_conn.ptnr2_label_asym_id A _struct_conn.ptnr2_label_comp_id MET _struct_conn.ptnr2_label_seq_id 2 _struct_conn.ptnr2_label_atom_id N _struct_conn.pdbx_ptnr2_label_alt_id ? _struct_conn.pdbx_ptnr2_PDB_ins_code ? _struct_conn.ptnr1_auth_asym_id A _struct_conn.ptnr1_auth_comp_id ACE _struct_conn.ptnr1_auth_seq_id 0 _struct_conn.ptnr2_auth_asym_id A _struct_conn.ptnr2_auth_comp_id MET _struct_conn.ptnr2_auth_seq_id 1 _struct_conn.ptnr2_symmetry 1_555 _struct_conn.pdbx_ptnr3_label_atom_id ? _struct_conn.pdbx_ptnr3_label_seq_id ? _struct_conn.pdbx_ptnr3_label_comp_id ? _struct_conn.pdbx_ptnr3_label_asym_id ? _struct_conn.pdbx_ptnr3_label_alt_id ? _struct_conn.pdbx_ptnr3_PDB_ins_code ? _struct_conn.details ? _struct_conn.pdbx_dist_value 1.342 _struct_conn.pdbx_value_order ? # _struct_conn_type.id covale _struct_conn_type.criteria ? _struct_conn_type.reference ? # _struct_mon_prot_cis.pdbx_id 1 _struct_mon_prot_cis.label_comp_id PRO _struct_mon_prot_cis.label_seq_id 254 _struct_mon_prot_cis.label_asym_id A _struct_mon_prot_cis.label_alt_id . _struct_mon_prot_cis.pdbx_PDB_ins_code ? _struct_mon_prot_cis.auth_comp_id PRO _struct_mon_prot_cis.auth_seq_id 253 _struct_mon_prot_cis.auth_asym_id A _struct_mon_prot_cis.pdbx_label_comp_id_2 PRO _struct_mon_prot_cis.pdbx_label_seq_id_2 255 _struct_mon_prot_cis.pdbx_label_asym_id_2 A _struct_mon_prot_cis.pdbx_PDB_ins_code_2 ? _struct_mon_prot_cis.pdbx_auth_comp_id_2 PRO _struct_mon_prot_cis.pdbx_auth_seq_id_2 254 _struct_mon_prot_cis.pdbx_auth_asym_id_2 A _struct_mon_prot_cis.pdbx_PDB_model_num 1 _struct_mon_prot_cis.pdbx_omega_angle -1.89 # loop_ _struct_sheet.id _struct_sheet.type _struct_sheet.number_strands _struct_sheet.details AA ? 5 ? AB ? 3 ? # loop_ _struct_sheet_order.sheet_id _struct_sheet_order.range_id_1 _struct_sheet_order.range_id_2 _struct_sheet_order.offset _struct_sheet_order.sense AA 1 2 ? anti-parallel AA 2 3 ? anti-parallel AA 3 4 ? anti-parallel AA 4 5 ? anti-parallel AB 1 2 ? anti-parallel AB 2 3 ? anti-parallel # loop_ _struct_sheet_range.sheet_id _struct_sheet_range.id _struct_sheet_range.beg_label_comp_id _struct_sheet_range.beg_label_asym_id _struct_sheet_range.beg_label_seq_id _struct_sheet_range.pdbx_beg_PDB_ins_code _struct_sheet_range.end_label_comp_id _struct_sheet_range.end_label_asym_id _struct_sheet_range.end_label_seq_id _struct_sheet_range.pdbx_end_PDB_ins_code _struct_sheet_range.beg_auth_comp_id _struct_sheet_range.beg_auth_asym_id _struct_sheet_range.beg_auth_seq_id _struct_sheet_range.end_auth_comp_id _struct_sheet_range.end_auth_asym_id _struct_sheet_range.end_auth_seq_id AA 1 PHE A 5 ? GLU A 13 ? PHE A 4 GLU A 12 AA 2 GLY A 17 ? ASN A 24 ? GLY A 16 ASN A 23 AA 3 VAL A 30 ? ILE A 36 ? VAL A 29 ILE A 35 AA 4 LYS A 76 ? GLU A 82 ? LYS A 75 GLU A 81 AA 5 LEU A 67 ? THR A 73 ? LEU A 66 THR A 72 AB 1 GLN A 86 ? ASP A 87 ? GLN A 85 ASP A 86 AB 2 LEU A 134 ? ILE A 136 ? LEU A 133 ILE A 135 AB 3 ILE A 142 ? LEU A 144 ? ILE A 141 LEU A 143 # loop_ _pdbx_struct_sheet_hbond.sheet_id _pdbx_struct_sheet_hbond.range_id_1 _pdbx_struct_sheet_hbond.range_id_2 _pdbx_struct_sheet_hbond.range_1_label_atom_id _pdbx_struct_sheet_hbond.range_1_label_comp_id _pdbx_struct_sheet_hbond.range_1_label_asym_id _pdbx_struct_sheet_hbond.range_1_label_seq_id _pdbx_struct_sheet_hbond.range_1_PDB_ins_code _pdbx_struct_sheet_hbond.range_1_auth_atom_id _pdbx_struct_sheet_hbond.range_1_auth_comp_id _pdbx_struct_sheet_hbond.range_1_auth_asym_id _pdbx_struct_sheet_hbond.range_1_auth_seq_id _pdbx_struct_sheet_hbond.range_2_label_atom_id _pdbx_struct_sheet_hbond.range_2_label_comp_id _pdbx_struct_sheet_hbond.range_2_label_asym_id _pdbx_struct_sheet_hbond.range_2_label_seq_id _pdbx_struct_sheet_hbond.range_2_PDB_ins_code _pdbx_struct_sheet_hbond.range_2_auth_atom_id _pdbx_struct_sheet_hbond.range_2_auth_comp_id _pdbx_struct_sheet_hbond.range_2_auth_asym_id _pdbx_struct_sheet_hbond.range_2_auth_seq_id AA 1 2 N ILE A 11 ? N ILE A 10 O VAL A 19 ? O VAL A 18 AA 2 3 N ALA A 22 ? N ALA A 21 O VAL A 31 ? O VAL A 30 AA 3 4 N ILE A 36 ? N ILE A 35 O LEU A 77 ? O LEU A 76 AA 4 5 O VAL A 80 ? O VAL A 79 N LEU A 68 ? N LEU A 67 AB 1 2 N GLN A 86 ? N GLN A 85 O ILE A 136 ? O ILE A 135 AB 2 3 N LEU A 135 ? N LEU A 134 O LYS A 143 ? O LYS A 142 # _struct_site.id AC1 _struct_site.pdbx_evidence_code Software _struct_site.pdbx_auth_asym_id ? _struct_site.pdbx_auth_comp_id ? _struct_site.pdbx_auth_seq_id ? _struct_site.pdbx_auth_ins_code ? _struct_site.pdbx_num_residues 11 _struct_site.details 'BINDING SITE FOR RESIDUE IM9 A1300' # loop_ _struct_site_gen.id _struct_site_gen.site_id _struct_site_gen.pdbx_num_res _struct_site_gen.label_comp_id _struct_site_gen.label_asym_id _struct_site_gen.label_seq_id _struct_site_gen.pdbx_auth_ins_code _struct_site_gen.auth_comp_id _struct_site_gen.auth_asym_id _struct_site_gen.auth_seq_id _struct_site_gen.label_atom_id _struct_site_gen.label_alt_id _struct_site_gen.symmetry _struct_site_gen.details 1 AC1 11 ILE A 11 ? ILE A 10 . ? 1_555 ? 2 AC1 11 VAL A 19 ? VAL A 18 . ? 1_555 ? 3 AC1 11 ALA A 32 ? ALA A 31 . ? 1_555 ? 4 AC1 11 LYS A 34 ? LYS A 33 . ? 1_555 ? 5 AC1 11 GLU A 82 ? GLU A 81 . ? 1_555 ? 6 AC1 11 LEU A 84 ? LEU A 83 . ? 1_555 ? 7 AC1 11 LYS A 90 ? LYS A 89 . ? 1_555 ? 8 AC1 11 GLN A 132 ? GLN A 131 . ? 1_555 ? 9 AC1 11 LEU A 135 ? LEU A 134 . ? 1_555 ? 10 AC1 11 ASP A 146 ? ASP A 145 . ? 1_555 ? 11 AC1 11 HOH C . ? HOH A 2152 . ? 1_555 ? # _database_PDB_matrix.entry_id 2VV9 _database_PDB_matrix.origx[1][1] 1.000000 _database_PDB_matrix.origx[1][2] 0.000000 _database_PDB_matrix.origx[1][3] 0.000000 _database_PDB_matrix.origx[2][1] 0.000000 _database_PDB_matrix.origx[2][2] 1.000000 _database_PDB_matrix.origx[2][3] 0.000000 _database_PDB_matrix.origx[3][1] 0.000000 _database_PDB_matrix.origx[3][2] 0.000000 _database_PDB_matrix.origx[3][3] 1.000000 _database_PDB_matrix.origx_vector[1] 0.00000 _database_PDB_matrix.origx_vector[2] 0.00000 _database_PDB_matrix.origx_vector[3] 0.00000 # _atom_sites.entry_id 2VV9 _atom_sites.fract_transf_matrix[1][1] 0.018779 _atom_sites.fract_transf_matrix[1][2] 0.000000 _atom_sites.fract_transf_matrix[1][3] 0.000000 _atom_sites.fract_transf_matrix[2][1] 0.000000 _atom_sites.fract_transf_matrix[2][2] 0.014054 _atom_sites.fract_transf_matrix[2][3] 0.000000 _atom_sites.fract_transf_matrix[3][1] 0.000000 _atom_sites.fract_transf_matrix[3][2] 0.000000 _atom_sites.fract_transf_matrix[3][3] 0.013902 _atom_sites.fract_transf_vector[1] 0.00000 _atom_sites.fract_transf_vector[2] 0.00000 _atom_sites.fract_transf_vector[3] 0.00000 # loop_ _atom_type.symbol C N O S # loop_ _pdbx_poly_seq_scheme.asym_id _pdbx_poly_seq_scheme.entity_id _pdbx_poly_seq_scheme.seq_id _pdbx_poly_seq_scheme.mon_id _pdbx_poly_seq_scheme.ndb_seq_num _pdbx_poly_seq_scheme.pdb_seq_num _pdbx_poly_seq_scheme.auth_seq_num _pdbx_poly_seq_scheme.pdb_mon_id _pdbx_poly_seq_scheme.auth_mon_id _pdbx_poly_seq_scheme.pdb_strand_id _pdbx_poly_seq_scheme.pdb_ins_code _pdbx_poly_seq_scheme.hetero A 1 1 ACE 1 0 0 ACE ACE A . n A 1 2 MET 2 1 1 MET MET A . n A 1 3 GLU 3 2 2 GLU GLU A . n A 1 4 ASN 4 3 3 ASN ASN A . n A 1 5 PHE 5 4 4 PHE PHE A . n A 1 6 GLN 6 5 5 GLN GLN A . n A 1 7 LYS 7 6 6 LYS LYS A . n A 1 8 VAL 8 7 7 VAL VAL A . n A 1 9 GLU 9 8 8 GLU GLU A . n A 1 10 LYS 10 9 9 LYS LYS A . n A 1 11 ILE 11 10 10 ILE ILE A . n A 1 12 GLY 12 11 11 GLY GLY A . n A 1 13 GLU 13 12 12 GLU GLU A . n A 1 14 GLY 14 13 13 GLY GLY A . n A 1 15 THR 15 14 14 THR THR A . n A 1 16 TYR 16 15 15 TYR TYR A . n A 1 17 GLY 17 16 16 GLY GLY A . n A 1 18 VAL 18 17 17 VAL VAL A . n A 1 19 VAL 19 18 18 VAL VAL A . n A 1 20 TYR 20 19 19 TYR TYR A . n A 1 21 LYS 21 20 20 LYS LYS A . n A 1 22 ALA 22 21 21 ALA ALA A . n A 1 23 ARG 23 22 22 ARG ARG A . n A 1 24 ASN 24 23 23 ASN ASN A . n A 1 25 LYS 25 24 24 LYS LYS A . n A 1 26 LEU 26 25 25 LEU LEU A . n A 1 27 THR 27 26 26 THR THR A . n A 1 28 GLY 28 27 27 GLY GLY A . n A 1 29 GLU 29 28 28 GLU GLU A . n A 1 30 VAL 30 29 29 VAL VAL A . n A 1 31 VAL 31 30 30 VAL VAL A . n A 1 32 ALA 32 31 31 ALA ALA A . n A 1 33 LEU 33 32 32 LEU LEU A . n A 1 34 LYS 34 33 33 LYS LYS A . n A 1 35 LYS 35 34 34 LYS LYS A . n A 1 36 ILE 36 35 35 ILE ILE A . n A 1 37 ARG 37 36 36 ARG ARG A . n A 1 38 LEU 38 37 37 LEU LEU A . n A 1 39 ASP 39 38 ? ? ? A . n A 1 40 THR 40 39 ? ? ? A . n A 1 41 GLU 41 40 ? ? ? A . n A 1 42 THR 42 41 ? ? ? A . n A 1 43 GLU 43 42 ? ? ? A . n A 1 44 GLY 44 43 ? ? ? A . n A 1 45 VAL 45 44 44 VAL VAL A . n A 1 46 PRO 46 45 45 PRO PRO A . n A 1 47 SER 47 46 46 SER SER A . n A 1 48 THR 48 47 47 THR THR A . n A 1 49 ALA 49 48 48 ALA ALA A . n A 1 50 ILE 50 49 49 ILE ILE A . n A 1 51 ARG 51 50 50 ARG ARG A . n A 1 52 GLU 52 51 51 GLU GLU A . n A 1 53 ILE 53 52 52 ILE ILE A . n A 1 54 SER 54 53 53 SER SER A . n A 1 55 LEU 55 54 54 LEU LEU A . n A 1 56 LEU 56 55 55 LEU LEU A . n A 1 57 LYS 57 56 56 LYS LYS A . n A 1 58 GLU 58 57 57 GLU GLU A . n A 1 59 LEU 59 58 58 LEU LEU A . n A 1 60 ASN 60 59 59 ASN ASN A . n A 1 61 HIS 61 60 60 HIS HIS A . n A 1 62 PRO 62 61 61 PRO PRO A . n A 1 63 ASN 63 62 62 ASN ASN A . n A 1 64 ILE 64 63 63 ILE ILE A . n A 1 65 VAL 65 64 64 VAL VAL A . n A 1 66 LYS 66 65 65 LYS LYS A . n A 1 67 LEU 67 66 66 LEU LEU A . n A 1 68 LEU 68 67 67 LEU LEU A . n A 1 69 ASP 69 68 68 ASP ASP A . n A 1 70 VAL 70 69 69 VAL VAL A . n A 1 71 ILE 71 70 70 ILE ILE A . n A 1 72 HIS 72 71 71 HIS HIS A . n A 1 73 THR 73 72 72 THR THR A . n A 1 74 GLU 74 73 73 GLU GLU A . n A 1 75 ASN 75 74 74 ASN ASN A . n A 1 76 LYS 76 75 75 LYS LYS A . n A 1 77 LEU 77 76 76 LEU LEU A . n A 1 78 TYR 78 77 77 TYR TYR A . n A 1 79 LEU 79 78 78 LEU LEU A . n A 1 80 VAL 80 79 79 VAL VAL A . n A 1 81 PHE 81 80 80 PHE PHE A . n A 1 82 GLU 82 81 81 GLU GLU A . n A 1 83 PHE 83 82 82 PHE PHE A . n A 1 84 LEU 84 83 83 LEU LEU A . n A 1 85 HIS 85 84 84 HIS HIS A . n A 1 86 GLN 86 85 85 GLN GLN A . n A 1 87 ASP 87 86 86 ASP ASP A . n A 1 88 LEU 88 87 87 LEU LEU A . n A 1 89 LYS 89 88 88 LYS LYS A . n A 1 90 LYS 90 89 89 LYS LYS A . n A 1 91 PHE 91 90 90 PHE PHE A . n A 1 92 MET 92 91 91 MET MET A . n A 1 93 ASP 93 92 92 ASP ASP A . n A 1 94 ALA 94 93 93 ALA ALA A . n A 1 95 SER 95 94 94 SER SER A . n A 1 96 ALA 96 95 95 ALA ALA A . n A 1 97 LEU 97 96 96 LEU LEU A . n A 1 98 THR 98 97 97 THR THR A . n A 1 99 GLY 99 98 98 GLY GLY A . n A 1 100 ILE 100 99 99 ILE ILE A . n A 1 101 PRO 101 100 100 PRO PRO A . n A 1 102 LEU 102 101 101 LEU LEU A . n A 1 103 PRO 103 102 102 PRO PRO A . n A 1 104 LEU 104 103 103 LEU LEU A . n A 1 105 ILE 105 104 104 ILE ILE A . n A 1 106 LYS 106 105 105 LYS LYS A . n A 1 107 SER 107 106 106 SER SER A . n A 1 108 TYR 108 107 107 TYR TYR A . n A 1 109 LEU 109 108 108 LEU LEU A . n A 1 110 PHE 110 109 109 PHE PHE A . n A 1 111 GLN 111 110 110 GLN GLN A . n A 1 112 LEU 112 111 111 LEU LEU A . n A 1 113 LEU 113 112 112 LEU LEU A . n A 1 114 GLN 114 113 113 GLN GLN A . n A 1 115 GLY 115 114 114 GLY GLY A . n A 1 116 LEU 116 115 115 LEU LEU A . n A 1 117 ALA 117 116 116 ALA ALA A . n A 1 118 PHE 118 117 117 PHE PHE A . n A 1 119 CYS 119 118 118 CYS CYS A . n A 1 120 HIS 120 119 119 HIS HIS A . n A 1 121 SER 121 120 120 SER SER A . n A 1 122 HIS 122 121 121 HIS HIS A . n A 1 123 ARG 123 122 122 ARG ARG A . n A 1 124 VAL 124 123 123 VAL VAL A . n A 1 125 LEU 125 124 124 LEU LEU A . n A 1 126 HIS 126 125 125 HIS HIS A . n A 1 127 ARG 127 126 126 ARG ARG A . n A 1 128 ASP 128 127 127 ASP ASP A . n A 1 129 LEU 129 128 128 LEU LEU A . n A 1 130 LYS 130 129 129 LYS LYS A . n A 1 131 PRO 131 130 130 PRO PRO A . n A 1 132 GLN 132 131 131 GLN GLN A . n A 1 133 ASN 133 132 132 ASN ASN A . n A 1 134 LEU 134 133 133 LEU LEU A . n A 1 135 LEU 135 134 134 LEU LEU A . n A 1 136 ILE 136 135 135 ILE ILE A . n A 1 137 ASN 137 136 136 ASN ASN A . n A 1 138 THR 138 137 137 THR THR A . n A 1 139 GLU 139 138 138 GLU GLU A . n A 1 140 GLY 140 139 139 GLY GLY A . n A 1 141 ALA 141 140 140 ALA ALA A . n A 1 142 ILE 142 141 141 ILE ILE A . n A 1 143 LYS 143 142 142 LYS LYS A . n A 1 144 LEU 144 143 143 LEU LEU A . n A 1 145 ALA 145 144 144 ALA ALA A . n A 1 146 ASP 146 145 145 ASP ASP A . n A 1 147 PHE 147 146 146 PHE PHE A . n A 1 148 GLY 148 147 147 GLY GLY A . n A 1 149 LEU 149 148 148 LEU LEU A . n A 1 150 ALA 150 149 149 ALA ALA A . n A 1 151 ARG 151 150 ? ? ? A . n A 1 152 ALA 152 151 ? ? ? A . n A 1 153 PHE 153 152 ? ? ? A . n A 1 154 GLY 154 153 ? ? ? A . n A 1 155 VAL 155 154 ? ? ? A . n A 1 156 PRO 156 155 ? ? ? A . n A 1 157 VAL 157 156 ? ? ? A . n A 1 158 ARG 158 157 ? ? ? A . n A 1 159 THR 159 158 ? ? ? A . n A 1 160 TYR 160 159 ? ? ? A . n A 1 161 THR 161 160 ? ? ? A . n A 1 162 HIS 162 161 ? ? ? A . n A 1 163 GLU 163 162 ? ? ? A . n A 1 164 VAL 164 163 163 VAL VAL A . n A 1 165 VAL 165 164 164 VAL VAL A . n A 1 166 THR 166 165 165 THR THR A . n A 1 167 LEU 167 166 166 LEU LEU A . n A 1 168 TRP 168 167 167 TRP TRP A . n A 1 169 TYR 169 168 168 TYR TYR A . n A 1 170 ARG 170 169 169 ARG ARG A . n A 1 171 ALA 171 170 170 ALA ALA A . n A 1 172 PRO 172 171 171 PRO PRO A . n A 1 173 GLU 173 172 172 GLU GLU A . n A 1 174 ILE 174 173 173 ILE ILE A . n A 1 175 LEU 175 174 174 LEU LEU A . n A 1 176 LEU 176 175 175 LEU LEU A . n A 1 177 GLY 177 176 176 GLY GLY A . n A 1 178 CYS 178 177 177 CYS CYS A . n A 1 179 LYS 179 178 178 LYS LYS A . n A 1 180 TYR 180 179 179 TYR TYR A . n A 1 181 TYR 181 180 180 TYR TYR A . n A 1 182 SER 182 181 181 SER SER A . n A 1 183 THR 183 182 182 THR THR A . n A 1 184 ALA 184 183 183 ALA ALA A . n A 1 185 VAL 185 184 184 VAL VAL A . n A 1 186 ASP 186 185 185 ASP ASP A . n A 1 187 ILE 187 186 186 ILE ILE A . n A 1 188 TRP 188 187 187 TRP TRP A . n A 1 189 SER 189 188 188 SER SER A . n A 1 190 LEU 190 189 189 LEU LEU A . n A 1 191 GLY 191 190 190 GLY GLY A . n A 1 192 CYS 192 191 191 CYS CYS A . n A 1 193 ILE 193 192 192 ILE ILE A . n A 1 194 PHE 194 193 193 PHE PHE A . n A 1 195 ALA 195 194 194 ALA ALA A . n A 1 196 GLU 196 195 195 GLU GLU A . n A 1 197 MET 197 196 196 MET MET A . n A 1 198 VAL 198 197 197 VAL VAL A . n A 1 199 THR 199 198 198 THR THR A . n A 1 200 ARG 200 199 199 ARG ARG A . n A 1 201 ARG 201 200 200 ARG ARG A . n A 1 202 ALA 202 201 201 ALA ALA A . n A 1 203 LEU 203 202 202 LEU LEU A . n A 1 204 PHE 204 203 203 PHE PHE A . n A 1 205 PRO 205 204 204 PRO PRO A . n A 1 206 GLY 206 205 205 GLY GLY A . n A 1 207 ASP 207 206 206 ASP ASP A . n A 1 208 SER 208 207 207 SER SER A . n A 1 209 GLU 209 208 208 GLU GLU A . n A 1 210 ILE 210 209 209 ILE ILE A . n A 1 211 ASP 211 210 210 ASP ASP A . n A 1 212 GLN 212 211 211 GLN GLN A . n A 1 213 LEU 213 212 212 LEU LEU A . n A 1 214 PHE 214 213 213 PHE PHE A . n A 1 215 ARG 215 214 214 ARG ARG A . n A 1 216 ILE 216 215 215 ILE ILE A . n A 1 217 PHE 217 216 216 PHE PHE A . n A 1 218 ARG 218 217 217 ARG ARG A . n A 1 219 THR 219 218 218 THR THR A . n A 1 220 LEU 220 219 219 LEU LEU A . n A 1 221 GLY 221 220 220 GLY GLY A . n A 1 222 THR 222 221 221 THR THR A . n A 1 223 PRO 223 222 222 PRO PRO A . n A 1 224 ASP 224 223 223 ASP ASP A . n A 1 225 GLU 225 224 224 GLU GLU A . n A 1 226 VAL 226 225 225 VAL VAL A . n A 1 227 VAL 227 226 226 VAL VAL A . n A 1 228 TRP 228 227 227 TRP TRP A . n A 1 229 PRO 229 228 228 PRO PRO A . n A 1 230 GLY 230 229 229 GLY GLY A . n A 1 231 VAL 231 230 230 VAL VAL A . n A 1 232 THR 232 231 231 THR THR A . n A 1 233 SER 233 232 232 SER SER A . n A 1 234 MET 234 233 233 MET MET A . n A 1 235 PRO 235 234 234 PRO PRO A . n A 1 236 ASP 236 235 235 ASP ASP A . n A 1 237 TYR 237 236 236 TYR TYR A . n A 1 238 LYS 238 237 237 LYS LYS A . n A 1 239 PRO 239 238 238 PRO PRO A . n A 1 240 SER 240 239 239 SER SER A . n A 1 241 PHE 241 240 240 PHE PHE A . n A 1 242 PRO 242 241 241 PRO PRO A . n A 1 243 LYS 243 242 242 LYS LYS A . n A 1 244 TRP 244 243 243 TRP TRP A . n A 1 245 ALA 245 244 244 ALA ALA A . n A 1 246 ARG 246 245 245 ARG ARG A . n A 1 247 GLN 247 246 246 GLN GLN A . n A 1 248 ASP 248 247 247 ASP ASP A . n A 1 249 PHE 249 248 248 PHE PHE A . n A 1 250 SER 250 249 249 SER SER A . n A 1 251 LYS 251 250 250 LYS LYS A . n A 1 252 VAL 252 251 251 VAL VAL A . n A 1 253 VAL 253 252 252 VAL VAL A . n A 1 254 PRO 254 253 253 PRO PRO A . n A 1 255 PRO 255 254 254 PRO PRO A . n A 1 256 LEU 256 255 255 LEU LEU A . n A 1 257 ASP 257 256 256 ASP ASP A . n A 1 258 GLU 258 257 257 GLU GLU A . n A 1 259 ASP 259 258 258 ASP ASP A . n A 1 260 GLY 260 259 259 GLY GLY A . n A 1 261 ARG 261 260 260 ARG ARG A . n A 1 262 SER 262 261 261 SER SER A . n A 1 263 LEU 263 262 262 LEU LEU A . n A 1 264 LEU 264 263 263 LEU LEU A . n A 1 265 SER 265 264 264 SER SER A . n A 1 266 GLN 266 265 265 GLN GLN A . n A 1 267 MET 267 266 266 MET MET A . n A 1 268 LEU 268 267 267 LEU LEU A . n A 1 269 HIS 269 268 268 HIS HIS A . n A 1 270 TYR 270 269 269 TYR TYR A . n A 1 271 ASP 271 270 270 ASP ASP A . n A 1 272 PRO 272 271 271 PRO PRO A . n A 1 273 ASN 273 272 272 ASN ASN A . n A 1 274 LYS 274 273 273 LYS LYS A . n A 1 275 ARG 275 274 274 ARG ARG A . n A 1 276 ILE 276 275 275 ILE ILE A . n A 1 277 SER 277 276 276 SER SER A . n A 1 278 ALA 278 277 277 ALA ALA A . n A 1 279 LYS 279 278 278 LYS LYS A . n A 1 280 ALA 280 279 279 ALA ALA A . n A 1 281 ALA 281 280 280 ALA ALA A . n A 1 282 LEU 282 281 281 LEU LEU A . n A 1 283 ALA 283 282 282 ALA ALA A . n A 1 284 HIS 284 283 283 HIS HIS A . n A 1 285 PRO 285 284 284 PRO PRO A . n A 1 286 PHE 286 285 285 PHE PHE A . n A 1 287 PHE 287 286 286 PHE PHE A . n A 1 288 GLN 288 287 287 GLN GLN A . n A 1 289 ASP 289 288 288 ASP ASP A . n A 1 290 VAL 290 289 289 VAL VAL A . n A 1 291 THR 291 290 290 THR THR A . n A 1 292 LYS 292 291 291 LYS LYS A . n A 1 293 PRO 293 292 292 PRO PRO A . n A 1 294 VAL 294 293 293 VAL VAL A . n A 1 295 PRO 295 294 294 PRO PRO A . n A 1 296 HIS 296 295 295 HIS HIS A . n A 1 297 LEU 297 296 296 LEU LEU A . n A 1 298 ARG 298 297 297 ARG ARG A . n A 1 299 LEU 299 298 298 LEU LEU A . n # loop_ _pdbx_nonpoly_scheme.asym_id _pdbx_nonpoly_scheme.entity_id _pdbx_nonpoly_scheme.mon_id _pdbx_nonpoly_scheme.ndb_seq_num _pdbx_nonpoly_scheme.pdb_seq_num _pdbx_nonpoly_scheme.auth_seq_num _pdbx_nonpoly_scheme.pdb_mon_id _pdbx_nonpoly_scheme.auth_mon_id _pdbx_nonpoly_scheme.pdb_strand_id _pdbx_nonpoly_scheme.pdb_ins_code B 2 IM9 1 1300 1300 IM9 IM9 A . C 3 HOH 1 2001 2001 HOH HOH A . C 3 HOH 2 2002 2002 HOH HOH A . C 3 HOH 3 2003 2003 HOH HOH A . C 3 HOH 4 2004 2004 HOH HOH A . C 3 HOH 5 2005 2005 HOH HOH A . C 3 HOH 6 2006 2006 HOH HOH A . C 3 HOH 7 2007 2007 HOH HOH A . C 3 HOH 8 2008 2008 HOH HOH A . C 3 HOH 9 2009 2009 HOH HOH A . C 3 HOH 10 2010 2010 HOH HOH A . C 3 HOH 11 2011 2011 HOH HOH A . C 3 HOH 12 2012 2012 HOH HOH A . C 3 HOH 13 2013 2013 HOH HOH A . C 3 HOH 14 2014 2014 HOH HOH A . C 3 HOH 15 2015 2015 HOH HOH A . C 3 HOH 16 2016 2016 HOH HOH A . C 3 HOH 17 2017 2017 HOH HOH A . C 3 HOH 18 2018 2018 HOH HOH A . C 3 HOH 19 2019 2019 HOH HOH A . C 3 HOH 20 2020 2020 HOH HOH A . C 3 HOH 21 2021 2021 HOH HOH A . C 3 HOH 22 2022 2022 HOH HOH A . C 3 HOH 23 2023 2023 HOH HOH A . C 3 HOH 24 2024 2024 HOH HOH A . C 3 HOH 25 2025 2025 HOH HOH A . C 3 HOH 26 2026 2026 HOH HOH A . C 3 HOH 27 2027 2027 HOH HOH A . C 3 HOH 28 2028 2028 HOH HOH A . C 3 HOH 29 2029 2029 HOH HOH A . C 3 HOH 30 2030 2030 HOH HOH A . C 3 HOH 31 2031 2031 HOH HOH A . C 3 HOH 32 2032 2032 HOH HOH A . C 3 HOH 33 2033 2033 HOH HOH A . C 3 HOH 34 2034 2034 HOH HOH A . C 3 HOH 35 2035 2035 HOH HOH A . C 3 HOH 36 2036 2036 HOH HOH A . C 3 HOH 37 2037 2037 HOH HOH A . C 3 HOH 38 2038 2038 HOH HOH A . C 3 HOH 39 2039 2039 HOH HOH A . C 3 HOH 40 2040 2040 HOH HOH A . C 3 HOH 41 2041 2041 HOH HOH A . C 3 HOH 42 2042 2042 HOH HOH A . C 3 HOH 43 2043 2043 HOH HOH A . C 3 HOH 44 2044 2044 HOH HOH A . C 3 HOH 45 2045 2045 HOH HOH A . C 3 HOH 46 2046 2046 HOH HOH A . C 3 HOH 47 2047 2047 HOH HOH A . C 3 HOH 48 2048 2048 HOH HOH A . C 3 HOH 49 2049 2049 HOH HOH A . C 3 HOH 50 2050 2050 HOH HOH A . C 3 HOH 51 2051 2051 HOH HOH A . C 3 HOH 52 2052 2052 HOH HOH A . C 3 HOH 53 2053 2053 HOH HOH A . C 3 HOH 54 2054 2054 HOH HOH A . C 3 HOH 55 2055 2055 HOH HOH A . C 3 HOH 56 2056 2056 HOH HOH A . C 3 HOH 57 2057 2057 HOH HOH A . C 3 HOH 58 2058 2058 HOH HOH A . C 3 HOH 59 2059 2059 HOH HOH A . C 3 HOH 60 2060 2060 HOH HOH A . C 3 HOH 61 2061 2061 HOH HOH A . C 3 HOH 62 2062 2062 HOH HOH A . C 3 HOH 63 2063 2063 HOH HOH A . C 3 HOH 64 2064 2064 HOH HOH A . C 3 HOH 65 2065 2065 HOH HOH A . C 3 HOH 66 2066 2066 HOH HOH A . C 3 HOH 67 2067 2067 HOH HOH A . C 3 HOH 68 2068 2068 HOH HOH A . C 3 HOH 69 2069 2069 HOH HOH A . C 3 HOH 70 2070 2070 HOH HOH A . C 3 HOH 71 2071 2071 HOH HOH A . C 3 HOH 72 2072 2072 HOH HOH A . C 3 HOH 73 2073 2073 HOH HOH A . C 3 HOH 74 2074 2074 HOH HOH A . C 3 HOH 75 2075 2075 HOH HOH A . C 3 HOH 76 2076 2076 HOH HOH A . C 3 HOH 77 2077 2077 HOH HOH A . C 3 HOH 78 2078 2078 HOH HOH A . C 3 HOH 79 2079 2079 HOH HOH A . C 3 HOH 80 2080 2080 HOH HOH A . C 3 HOH 81 2081 2081 HOH HOH A . C 3 HOH 82 2082 2082 HOH HOH A . C 3 HOH 83 2083 2083 HOH HOH A . C 3 HOH 84 2084 2084 HOH HOH A . C 3 HOH 85 2085 2085 HOH HOH A . C 3 HOH 86 2086 2086 HOH HOH A . C 3 HOH 87 2087 2087 HOH HOH A . C 3 HOH 88 2088 2088 HOH HOH A . C 3 HOH 89 2089 2089 HOH HOH A . C 3 HOH 90 2090 2090 HOH HOH A . C 3 HOH 91 2091 2091 HOH HOH A . C 3 HOH 92 2092 2092 HOH HOH A . C 3 HOH 93 2093 2093 HOH HOH A . C 3 HOH 94 2094 2094 HOH HOH A . C 3 HOH 95 2095 2095 HOH HOH A . C 3 HOH 96 2096 2096 HOH HOH A . C 3 HOH 97 2097 2097 HOH HOH A . C 3 HOH 98 2098 2098 HOH HOH A . C 3 HOH 99 2099 2099 HOH HOH A . C 3 HOH 100 2100 2100 HOH HOH A . C 3 HOH 101 2101 2101 HOH HOH A . C 3 HOH 102 2102 2102 HOH HOH A . C 3 HOH 103 2103 2103 HOH HOH A . C 3 HOH 104 2104 2104 HOH HOH A . C 3 HOH 105 2105 2105 HOH HOH A . C 3 HOH 106 2106 2106 HOH HOH A . C 3 HOH 107 2107 2107 HOH HOH A . C 3 HOH 108 2108 2108 HOH HOH A . C 3 HOH 109 2109 2109 HOH HOH A . C 3 HOH 110 2110 2110 HOH HOH A . C 3 HOH 111 2111 2111 HOH HOH A . C 3 HOH 112 2112 2112 HOH HOH A . C 3 HOH 113 2113 2113 HOH HOH A . C 3 HOH 114 2114 2114 HOH HOH A . C 3 HOH 115 2115 2115 HOH HOH A . C 3 HOH 116 2116 2116 HOH HOH A . C 3 HOH 117 2117 2117 HOH HOH A . C 3 HOH 118 2118 2118 HOH HOH A . C 3 HOH 119 2119 2119 HOH HOH A . C 3 HOH 120 2120 2120 HOH HOH A . C 3 HOH 121 2121 2121 HOH HOH A . C 3 HOH 122 2122 2122 HOH HOH A . C 3 HOH 123 2123 2123 HOH HOH A . C 3 HOH 124 2124 2124 HOH HOH A . C 3 HOH 125 2125 2125 HOH HOH A . C 3 HOH 126 2126 2126 HOH HOH A . C 3 HOH 127 2127 2127 HOH HOH A . C 3 HOH 128 2128 2128 HOH HOH A . C 3 HOH 129 2129 2129 HOH HOH A . C 3 HOH 130 2130 2130 HOH HOH A . C 3 HOH 131 2131 2131 HOH HOH A . C 3 HOH 132 2132 2132 HOH HOH A . C 3 HOH 133 2133 2133 HOH HOH A . C 3 HOH 134 2134 2134 HOH HOH A . C 3 HOH 135 2135 2135 HOH HOH A . C 3 HOH 136 2136 2136 HOH HOH A . C 3 HOH 137 2137 2137 HOH HOH A . C 3 HOH 138 2138 2138 HOH HOH A . C 3 HOH 139 2139 2139 HOH HOH A . C 3 HOH 140 2140 2140 HOH HOH A . C 3 HOH 141 2141 2141 HOH HOH A . C 3 HOH 142 2142 2142 HOH HOH A . C 3 HOH 143 2143 2143 HOH HOH A . C 3 HOH 144 2144 2144 HOH HOH A . C 3 HOH 145 2145 2145 HOH HOH A . C 3 HOH 146 2146 2146 HOH HOH A . C 3 HOH 147 2147 2147 HOH HOH A . C 3 HOH 148 2148 2148 HOH HOH A . C 3 HOH 149 2149 2149 HOH HOH A . C 3 HOH 150 2150 2150 HOH HOH A . C 3 HOH 151 2151 2151 HOH HOH A . C 3 HOH 152 2152 2152 HOH HOH A . # _pdbx_struct_assembly.id 1 _pdbx_struct_assembly.details author_and_software_defined_assembly _pdbx_struct_assembly.method_details PQS _pdbx_struct_assembly.oligomeric_details monomeric _pdbx_struct_assembly.oligomeric_count 1 # _pdbx_struct_assembly_gen.assembly_id 1 _pdbx_struct_assembly_gen.oper_expression 1 _pdbx_struct_assembly_gen.asym_id_list A,B,C # _pdbx_struct_oper_list.id 1 _pdbx_struct_oper_list.type 'identity operation' _pdbx_struct_oper_list.name 1_555 _pdbx_struct_oper_list.symmetry_operation x,y,z _pdbx_struct_oper_list.matrix[1][1] 1.0000000000 _pdbx_struct_oper_list.matrix[1][2] 0.0000000000 _pdbx_struct_oper_list.matrix[1][3] 0.0000000000 _pdbx_struct_oper_list.vector[1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][1] 0.0000000000 _pdbx_struct_oper_list.matrix[2][2] 1.0000000000 _pdbx_struct_oper_list.matrix[2][3] 0.0000000000 _pdbx_struct_oper_list.vector[2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][1] 0.0000000000 _pdbx_struct_oper_list.matrix[3][2] 0.0000000000 _pdbx_struct_oper_list.matrix[3][3] 1.0000000000 _pdbx_struct_oper_list.vector[3] 0.0000000000 # loop_ _pdbx_audit_revision_history.ordinal _pdbx_audit_revision_history.data_content_type _pdbx_audit_revision_history.major_revision _pdbx_audit_revision_history.minor_revision _pdbx_audit_revision_history.revision_date 1 'Structure model' 1 0 2008-08-05 2 'Structure model' 1 1 2011-07-13 3 'Structure model' 1 2 2019-04-24 # _pdbx_audit_revision_details.ordinal 1 _pdbx_audit_revision_details.revision_ordinal 1 _pdbx_audit_revision_details.data_content_type 'Structure model' _pdbx_audit_revision_details.provider repository _pdbx_audit_revision_details.type 'Initial release' _pdbx_audit_revision_details.description ? # loop_ _pdbx_audit_revision_group.ordinal _pdbx_audit_revision_group.revision_ordinal _pdbx_audit_revision_group.data_content_type _pdbx_audit_revision_group.group 1 2 'Structure model' Advisory 2 2 'Structure model' 'Version format compliance' 3 3 'Structure model' 'Data collection' 4 3 'Structure model' 'Derived calculations' 5 3 'Structure model' Other 6 3 'Structure model' 'Source and taxonomy' # loop_ _pdbx_audit_revision_category.ordinal _pdbx_audit_revision_category.revision_ordinal _pdbx_audit_revision_category.data_content_type _pdbx_audit_revision_category.category 1 3 'Structure model' entity_src_gen 2 3 'Structure model' pdbx_database_proc 3 3 'Structure model' pdbx_database_status 4 3 'Structure model' struct_conn # loop_ _pdbx_audit_revision_item.ordinal _pdbx_audit_revision_item.revision_ordinal _pdbx_audit_revision_item.data_content_type _pdbx_audit_revision_item.item 1 3 'Structure model' '_entity_src_gen.pdbx_host_org_cell_line' 2 3 'Structure model' '_pdbx_database_status.recvd_author_approval' 3 3 'Structure model' '_struct_conn.pdbx_leaving_atom_flag' # _pdbx_refine_tls.pdbx_refine_id 'X-RAY DIFFRACTION' _pdbx_refine_tls.id 1 _pdbx_refine_tls.details ? _pdbx_refine_tls.method refined _pdbx_refine_tls.origin_x 2.3384 _pdbx_refine_tls.origin_y 30.3507 _pdbx_refine_tls.origin_z 21.8917 _pdbx_refine_tls.T[1][1] 0.0459 _pdbx_refine_tls.T[2][2] 0.0002 _pdbx_refine_tls.T[3][3] 0.0836 _pdbx_refine_tls.T[1][2] 0.0030 _pdbx_refine_tls.T[1][3] -0.0011 _pdbx_refine_tls.T[2][3] 0.0016 _pdbx_refine_tls.L[1][1] 1.2356 _pdbx_refine_tls.L[2][2] 1.3818 _pdbx_refine_tls.L[3][3] 3.4132 _pdbx_refine_tls.L[1][2] 0.4903 _pdbx_refine_tls.L[1][3] -0.4513 _pdbx_refine_tls.L[2][3] -0.5029 _pdbx_refine_tls.S[1][1] 0.0253 _pdbx_refine_tls.S[1][2] 0.1463 _pdbx_refine_tls.S[1][3] -0.0042 _pdbx_refine_tls.S[2][1] -0.1332 _pdbx_refine_tls.S[2][2] 0.0219 _pdbx_refine_tls.S[2][3] 0.1545 _pdbx_refine_tls.S[3][1] 0.0996 _pdbx_refine_tls.S[3][2] -0.1442 _pdbx_refine_tls.S[3][3] -0.0472 # _pdbx_refine_tls_group.pdbx_refine_id 'X-RAY DIFFRACTION' _pdbx_refine_tls_group.id 1 _pdbx_refine_tls_group.refine_tls_id 1 _pdbx_refine_tls_group.beg_auth_asym_id A _pdbx_refine_tls_group.beg_auth_seq_id 0 _pdbx_refine_tls_group.beg_label_asym_id ? _pdbx_refine_tls_group.beg_label_seq_id ? _pdbx_refine_tls_group.end_auth_asym_id A _pdbx_refine_tls_group.end_auth_seq_id 298 _pdbx_refine_tls_group.end_label_asym_id ? _pdbx_refine_tls_group.end_label_seq_id ? _pdbx_refine_tls_group.selection ? _pdbx_refine_tls_group.selection_details ? # loop_ _software.name _software.classification _software.version _software.citation_id _software.pdbx_ordinal REFMAC refinement 5.1.17 ? 1 MOSFLM 'data reduction' . ? 2 TRUNCATE 'data scaling' . ? 3 AMoRE phasing . ? 4 # _pdbx_entry_details.entry_id 2VV9 _pdbx_entry_details.compound_details ? _pdbx_entry_details.source_details ? _pdbx_entry_details.nonpolymer_details 'ACETYL GROUP (ACE): ACETYLATION OF N-TERMINAL METHIONINE' _pdbx_entry_details.sequence_details ? # loop_ _pdbx_validate_rmsd_angle.id _pdbx_validate_rmsd_angle.PDB_model_num _pdbx_validate_rmsd_angle.auth_atom_id_1 _pdbx_validate_rmsd_angle.auth_asym_id_1 _pdbx_validate_rmsd_angle.auth_comp_id_1 _pdbx_validate_rmsd_angle.auth_seq_id_1 _pdbx_validate_rmsd_angle.PDB_ins_code_1 _pdbx_validate_rmsd_angle.label_alt_id_1 _pdbx_validate_rmsd_angle.auth_atom_id_2 _pdbx_validate_rmsd_angle.auth_asym_id_2 _pdbx_validate_rmsd_angle.auth_comp_id_2 _pdbx_validate_rmsd_angle.auth_seq_id_2 _pdbx_validate_rmsd_angle.PDB_ins_code_2 _pdbx_validate_rmsd_angle.label_alt_id_2 _pdbx_validate_rmsd_angle.auth_atom_id_3 _pdbx_validate_rmsd_angle.auth_asym_id_3 _pdbx_validate_rmsd_angle.auth_comp_id_3 _pdbx_validate_rmsd_angle.auth_seq_id_3 _pdbx_validate_rmsd_angle.PDB_ins_code_3 _pdbx_validate_rmsd_angle.label_alt_id_3 _pdbx_validate_rmsd_angle.angle_value _pdbx_validate_rmsd_angle.angle_target_value _pdbx_validate_rmsd_angle.angle_deviation _pdbx_validate_rmsd_angle.angle_standard_deviation _pdbx_validate_rmsd_angle.linker_flag 1 1 N A GLY 27 ? ? CA A GLY 27 ? ? C A GLY 27 ? ? 129.14 113.10 16.04 2.50 N 2 1 CB A ASP 92 ? ? CG A ASP 92 ? ? OD2 A ASP 92 ? ? 125.03 118.30 6.73 0.90 N 3 1 CA A CYS 118 ? ? CB A CYS 118 ? ? SG A CYS 118 ? B 123.76 114.20 9.56 1.10 N 4 1 NE A ARG 126 ? B CZ A ARG 126 ? B NH1 A ARG 126 ? B 117.17 120.30 -3.13 0.50 N 5 1 NE A ARG 126 ? B CZ A ARG 126 ? B NH2 A ARG 126 ? B 123.88 120.30 3.58 0.50 N 6 1 NE A ARG 169 ? ? CZ A ARG 169 ? ? NH1 A ARG 169 ? ? 123.63 120.30 3.33 0.50 N 7 1 CB A ASP 210 ? ? CG A ASP 210 ? ? OD2 A ASP 210 ? ? 123.73 118.30 5.43 0.90 N 8 1 CB A ASP 223 ? ? CG A ASP 223 ? ? OD2 A ASP 223 ? ? 125.32 118.30 7.02 0.90 N 9 1 CB A ASP 256 ? ? CG A ASP 256 ? ? OD2 A ASP 256 ? ? 123.88 118.30 5.58 0.90 N # loop_ _pdbx_validate_torsion.id _pdbx_validate_torsion.PDB_model_num _pdbx_validate_torsion.auth_comp_id _pdbx_validate_torsion.auth_asym_id _pdbx_validate_torsion.auth_seq_id _pdbx_validate_torsion.PDB_ins_code _pdbx_validate_torsion.label_alt_id _pdbx_validate_torsion.phi _pdbx_validate_torsion.psi 1 1 TYR A 15 ? ? -67.88 -79.75 2 1 ASN A 23 ? ? -52.93 109.05 3 1 THR A 26 ? ? -162.55 47.93 4 1 ARG A 36 ? ? -9.21 81.24 5 1 ASN A 74 ? ? 88.35 -35.66 6 1 ARG A 126 ? ? 85.21 -25.04 7 1 TYR A 179 ? ? -111.17 62.99 # _pdbx_validate_peptide_omega.id 1 _pdbx_validate_peptide_omega.PDB_model_num 1 _pdbx_validate_peptide_omega.auth_comp_id_1 LEU _pdbx_validate_peptide_omega.auth_asym_id_1 A _pdbx_validate_peptide_omega.auth_seq_id_1 25 _pdbx_validate_peptide_omega.PDB_ins_code_1 ? _pdbx_validate_peptide_omega.label_alt_id_1 ? _pdbx_validate_peptide_omega.auth_comp_id_2 THR _pdbx_validate_peptide_omega.auth_asym_id_2 A _pdbx_validate_peptide_omega.auth_seq_id_2 26 _pdbx_validate_peptide_omega.PDB_ins_code_2 ? _pdbx_validate_peptide_omega.label_alt_id_2 ? _pdbx_validate_peptide_omega.omega -146.01 # loop_ _pdbx_unobs_or_zero_occ_atoms.id _pdbx_unobs_or_zero_occ_atoms.PDB_model_num _pdbx_unobs_or_zero_occ_atoms.polymer_flag _pdbx_unobs_or_zero_occ_atoms.occupancy_flag _pdbx_unobs_or_zero_occ_atoms.auth_asym_id _pdbx_unobs_or_zero_occ_atoms.auth_comp_id _pdbx_unobs_or_zero_occ_atoms.auth_seq_id _pdbx_unobs_or_zero_occ_atoms.PDB_ins_code _pdbx_unobs_or_zero_occ_atoms.auth_atom_id _pdbx_unobs_or_zero_occ_atoms.label_alt_id _pdbx_unobs_or_zero_occ_atoms.label_asym_id _pdbx_unobs_or_zero_occ_atoms.label_comp_id _pdbx_unobs_or_zero_occ_atoms.label_seq_id _pdbx_unobs_or_zero_occ_atoms.label_atom_id 1 1 Y 1 A GLU 2 ? CG ? A GLU 3 CG 2 1 Y 1 A GLU 2 ? CD ? A GLU 3 CD 3 1 Y 1 A GLU 2 ? OE1 ? A GLU 3 OE1 4 1 Y 1 A GLU 2 ? OE2 ? A GLU 3 OE2 5 1 Y 1 A GLN 5 ? CG ? A GLN 6 CG 6 1 Y 1 A GLN 5 ? CD ? A GLN 6 CD 7 1 Y 1 A GLN 5 ? OE1 ? A GLN 6 OE1 8 1 Y 1 A GLN 5 ? NE2 ? A GLN 6 NE2 9 1 Y 1 A GLU 12 ? CG ? A GLU 13 CG 10 1 Y 1 A GLU 12 ? CD ? A GLU 13 CD 11 1 Y 1 A GLU 12 ? OE1 ? A GLU 13 OE1 12 1 Y 1 A GLU 12 ? OE2 ? A GLU 13 OE2 13 1 Y 1 A TYR 15 ? CG ? A TYR 16 CG 14 1 Y 1 A TYR 15 ? CD1 ? A TYR 16 CD1 15 1 Y 1 A TYR 15 ? CD2 ? A TYR 16 CD2 16 1 Y 1 A TYR 15 ? CE1 ? A TYR 16 CE1 17 1 Y 1 A TYR 15 ? CE2 ? A TYR 16 CE2 18 1 Y 1 A TYR 15 ? CZ ? A TYR 16 CZ 19 1 Y 1 A TYR 15 ? OH ? A TYR 16 OH 20 1 Y 1 A LEU 25 ? CG ? A LEU 26 CG 21 1 Y 1 A LEU 25 ? CD1 ? A LEU 26 CD1 22 1 Y 1 A LEU 25 ? CD2 ? A LEU 26 CD2 23 1 Y 1 A LYS 34 ? CG ? A LYS 35 CG 24 1 Y 1 A LYS 34 ? CD ? A LYS 35 CD 25 1 Y 1 A LYS 34 ? CE ? A LYS 35 CE 26 1 Y 1 A LYS 34 ? NZ ? A LYS 35 NZ 27 1 Y 1 A ARG 36 ? CG ? A ARG 37 CG 28 1 Y 1 A ARG 36 ? CD ? A ARG 37 CD 29 1 Y 1 A ARG 36 ? NE ? A ARG 37 NE 30 1 Y 1 A ARG 36 ? CZ ? A ARG 37 CZ 31 1 Y 1 A ARG 36 ? NH1 ? A ARG 37 NH1 32 1 Y 1 A ARG 36 ? NH2 ? A ARG 37 NH2 33 1 Y 1 A LEU 37 ? CG ? A LEU 38 CG 34 1 Y 1 A LEU 37 ? CD1 ? A LEU 38 CD1 35 1 Y 1 A LEU 37 ? CD2 ? A LEU 38 CD2 36 1 Y 1 A VAL 44 ? CG1 ? A VAL 45 CG1 37 1 Y 1 A VAL 44 ? CG2 ? A VAL 45 CG2 38 1 Y 1 A THR 72 ? OG1 ? A THR 73 OG1 39 1 Y 1 A THR 72 ? CG2 ? A THR 73 CG2 40 1 Y 1 A GLU 73 ? CG ? A GLU 74 CG 41 1 Y 1 A GLU 73 ? CD ? A GLU 74 CD 42 1 Y 1 A GLU 73 ? OE1 ? A GLU 74 OE1 43 1 Y 1 A GLU 73 ? OE2 ? A GLU 74 OE2 44 1 Y 1 A ASN 74 ? CG ? A ASN 75 CG 45 1 Y 1 A ASN 74 ? OD1 ? A ASN 75 OD1 46 1 Y 1 A ASN 74 ? ND2 ? A ASN 75 ND2 47 1 Y 1 A LYS 75 ? CG ? A LYS 76 CG 48 1 Y 1 A LYS 75 ? CD ? A LYS 76 CD 49 1 Y 1 A LYS 75 ? CE ? A LYS 76 CE 50 1 Y 1 A LYS 75 ? NZ ? A LYS 76 NZ 51 1 Y 1 A LEU 96 ? CG ? A LEU 97 CG 52 1 Y 1 A LEU 96 ? CD1 ? A LEU 97 CD1 53 1 Y 1 A LEU 96 ? CD2 ? A LEU 97 CD2 54 1 Y 1 A LYS 178 ? CG ? A LYS 179 CG 55 1 Y 1 A LYS 178 ? CD ? A LYS 179 CD 56 1 Y 1 A LYS 178 ? CE ? A LYS 179 CE 57 1 Y 1 A LYS 178 ? NZ ? A LYS 179 NZ 58 1 Y 1 A LYS 278 ? CG ? A LYS 279 CG 59 1 Y 1 A LYS 278 ? CD ? A LYS 279 CD 60 1 Y 1 A LYS 278 ? CE ? A LYS 279 CE 61 1 Y 1 A LYS 278 ? NZ ? A LYS 279 NZ 62 1 Y 1 A ARG 297 ? CG ? A ARG 298 CG 63 1 Y 1 A ARG 297 ? CD ? A ARG 298 CD 64 1 Y 1 A ARG 297 ? NE ? A ARG 298 NE 65 1 Y 1 A ARG 297 ? CZ ? A ARG 298 CZ 66 1 Y 1 A ARG 297 ? NH1 ? A ARG 298 NH1 67 1 Y 1 A ARG 297 ? NH2 ? A ARG 298 NH2 # loop_ _pdbx_unobs_or_zero_occ_residues.id _pdbx_unobs_or_zero_occ_residues.PDB_model_num _pdbx_unobs_or_zero_occ_residues.polymer_flag _pdbx_unobs_or_zero_occ_residues.occupancy_flag _pdbx_unobs_or_zero_occ_residues.auth_asym_id _pdbx_unobs_or_zero_occ_residues.auth_comp_id _pdbx_unobs_or_zero_occ_residues.auth_seq_id _pdbx_unobs_or_zero_occ_residues.PDB_ins_code _pdbx_unobs_or_zero_occ_residues.label_asym_id _pdbx_unobs_or_zero_occ_residues.label_comp_id _pdbx_unobs_or_zero_occ_residues.label_seq_id 1 1 Y 1 A ASP 38 ? A ASP 39 2 1 Y 1 A THR 39 ? A THR 40 3 1 Y 1 A GLU 40 ? A GLU 41 4 1 Y 1 A THR 41 ? A THR 42 5 1 Y 1 A GLU 42 ? A GLU 43 6 1 Y 1 A GLY 43 ? A GLY 44 7 1 Y 1 A ARG 150 ? A ARG 151 8 1 Y 1 A ALA 151 ? A ALA 152 9 1 Y 1 A PHE 152 ? A PHE 153 10 1 Y 1 A GLY 153 ? A GLY 154 11 1 Y 1 A VAL 154 ? A VAL 155 12 1 Y 1 A PRO 155 ? A PRO 156 13 1 Y 1 A VAL 156 ? A VAL 157 14 1 Y 1 A ARG 157 ? A ARG 158 15 1 Y 1 A THR 158 ? A THR 159 16 1 Y 1 A TYR 159 ? A TYR 160 17 1 Y 1 A THR 160 ? A THR 161 18 1 Y 1 A HIS 161 ? A HIS 162 19 1 Y 1 A GLU 162 ? A GLU 163 # loop_ _pdbx_entity_nonpoly.entity_id _pdbx_entity_nonpoly.name _pdbx_entity_nonpoly.comp_id 2 '2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol' IM9 3 water HOH #